Prescription drug · NDA
Gleolan (aminolevulinic acid hydrochloride) NDC 71469-231
Aminolevulinic acid hydrochloride 1500 mg/1 · Powder, For solution · Oral · NX DEVELOPMENT CORP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71469-231-01 | 71469023101 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71469-231-01) / 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSEMarketed from Mar 14, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Gleolan
- Generic name (nonproprietary)
- aminolevulinic acid hydrochloride
- Active ingredients
- Aminolevulinic acid hydrochloride — 1500 mg/1
- Dosage form
- Powder, For solution
- Route
- Oral
- Labeler
- NX DEVELOPMENT CORP
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 208630
- Marketing start
- Listing expires
- Other FDA classes
- Fluorescence Contrast Activity (Mechanism)Porphyrinogens (Chemical structure)
- Identifiers
- Product ID 71469-231_957499a8-90f5-4cbd-916d-abfd8251e1b4SPL ID 957499a8-90f5-4cbd-916d-abfd8251e1b4SPL set ID cdeded66-0017-42cf-9471-13f231014323UNII V35KBM8JGRUPC 0371469231015
- Pharmacologic class
- Optical Imaging Agent; Porphyrin Precursor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471469023101followed by a unit qualifier and the quantityPackage 71469-0231-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Gleolan is indicated in patients with glioma [suspected World Health Organization (WHO) Grades III or IV on preoperative imaging] as an adjunct for the visualization of malignant tissue during surgery. Gleolan is an optical imaging agent indicated in patients with glioma (suspected World Health Organization Grades III or IV on preoperative imaging) as an adjunct for the visualization of malignant tissue during surgery. ( 1 )
Excerpt only. Read the full label for complete information.